Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

IND application for NeXstar antiangiogenesis drug approved by FDA

Sep. 4, 1998

PMA for KeraVision Ring accepted for filing

Sep. 3, 1998

IL-1 blockers CK-119 and CK-122 inhibit corneal fibroblast-like cell proliferation

Aug. 28, 1998

Future antiglaucoma drug candidates added to the pipeline at Alcon

Aug. 24, 1998

PGF2alpha derivative from Allergan reduces ocular hypertension in monkeys

Aug. 20, 1998

Sugen reaches milestone in collaborative agreement with Allergan

Aug. 10, 1998

First SELEX compound from NeXstar heads for clinical trials in ARMD

July 27, 1998

Troponin I inhibits retinal angiogenesis in animal studies

July 27, 1998

Herpes simplex virus vaccine reduces HSV-1 corneal disease

July 24, 1998

BioLon receives FDA approval

July 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...